The GLP is committed to full transparency. Download and review our just-released 2019 Annual Report.

FDA lifts 2016 import ban on GMO AquAdvantage salmon, confirms fish safe to eat

| | March 11, 2019

The Food & Drug Administration announced [March 8] that it will be deactivating a 2016 import alert that prevented genetically engineered (GE) salmon from entering the U.S. AquAdvantage salmon has been genetically engineered to reach a key aquaculture industry growth marker faster [than] its non-GE Atlantic salmon counterpart.

“As was determined during the FDA’s 2015 review, this fish is safe to eat, the genetic construct added to the fish’s genome is safe for the animal….” FDA said.

FDA stated that, with the deactivation of the import alert, AquAdvantage salmon eggs can now be imported to AquaBounty Technologies’ contained growout facility in Indiana to be raised into salmon for food. On April 26, 2018, FDA approved a facility near Albany, Ind., for rearing AquAdvantage Salmon. This secure, land-based tank system in Indiana is AquaBounty Technologies’ sole approved growing facility in the U.S.

Related article:  After centuries of failed attempts at breeding a blue rose, biotechnology does the trick

AquAdvantage salmon, which are all female and effectively sterile, would be raised in a secure indoor facility in freshwater, land-based tanks. Multiple physical containment measures like nets, screens and filters would prevent any fish from escaping….

Read full, original article: FDA green lights GE salmon

The GLP aggregated and excerpted this article to reflect the diversity of news, opinion, and analysis. Click the link above to read the full, original article.
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend